New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
06:34 EDTWLP, CNC, HNT, CI, HS, MOH, UNH, WCG, AGP, AET, HUMMore than 3M Americans have chosen Obamacare plans, Politico reports
Approximately 3.3M Americans had signed up for health insurance plans through Obamacare exchanges as of the end of January, Politico reported. Last month, 27% of those signing up for plans were between 18 and 34 years old, representing a slight increase in interest in Obamacare among those in that demographic, the website stated. Publicly traded companies in the health insurance space include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP). Reference Link
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 19, 2015
12:19 EDTHUM, CI, AET, UNHOn The Fly: Top stock stories at midday
Stocks have struggled for direction since the open and spent the morning moving in a narrow range. The Dow has held up fairly well considering the weakness seen in UnitedHealth (UNH), which has declined after the insurer cut its fiscal 2015 profit guidance, citing weakness in individual health insurance policies it markets through exchanges. Oil prices remain under pressure, with benchmark U.S. crude trading back below $42 per barrel. ECONOMIC EVENTS: In the U.S., initial jobless claims continued to hover around four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the euro-area. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as widely expected. COMPANY NEWS: The shares of health insurer UnitedHealth and a number of other companies in the sector are falling after the Dow member lowered its profit outlook for this fiscal year, citing weakness in individual health insurance policies it markets through exchanges. UnitedHealth said it has pulled back on its marketing efforts for individual exchange products in 2016 and is "evaluating the viability of the insurance exchange product segment." Near noon, UnitedHealth fell about 5%, while Aetna (AET) declined nearly 6%, Humana (HUM) droped more than 3.5%, Anthem (ANTM) declined over 6% and Cigna (CI) slid 4%... Press reports indicate that talks between Pfizer (PFE) and Allergan (AGN) are heating up and that a deal is nearing, but simultaneously the U.S. government's rhetoric around the type of "inversion" deal the two pharmaceutical giants are discussing is getting ratcheted up as well. Last night, Bloomberg reported that Pfizer is nearing an agreement to acquire Allergan for $370 to $380 per share, citing people familiar with the matter. The two companies are aiming to announce a deal as early as Monday, sources told the publication. However, CNBC's David Faber reported, citing sources, that a deal will not be announced on Monday, but Pfizer and Allergan are in the "final innings" of merger talks. The deal will consist of all stock and Pfizer is likely to offer 11-plus shares per Allergan share, Faber noted. Amid the reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers... Square (SQ) completed its initial public offering of stock and rose about $4 per share to trade near $13 around noon after pricing last night at $9 per share. CEO Jack Dorsey, who leads both Square and Twitter (TWTR) as CEO, said in an interview following the opening that the teams behind him make him able to simultaneously hold both positions. Twitter rose about 1.4% to $26.25 in midday trading following Square's entry to the public markets. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which rallied 22% after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was (CTRP), which gained 19% after no fewer than three analysts raised their price target on the company's stock following upbeat fourth quarter earnings. Among the noteworthy losers was Kirkland's (KIRK), which fell 30% after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower was AMAG Pharmaceuticals (AMAG), which lost over 8.5% after it received a complete response letter from the FDA for a single-dose vial of Makena, a treatment to reduce the risk of preterm birth in at-risk patients. In addition, Best Buy (BBY) fell 3% after it reported better than expected third quarter earnings but worse than expected same-store sales growth and also guided toward "near-flat" revenue for its domestic business in the holiday quarter. INDEXES: Near midday, the Dow was down 17.44, or 0.1%, to 17,719.72, the Nasdaq was up 2.36, or 0.05%, to 5,077.57, and the S&P 500 was down 3.67, or 0.18%, to 2,079.91.
12:18 EDTUNHUnitedHealth volatility increases after lowering FY15 guidance
Subscribe for More Information
11:01 EDTHNTHealth Net reaches new agreement covering Tucson-area providers
Subscribe for More Information
10:58 EDTUNH, AET, HUM, CIAnalysts say possible exchange exit positive for battered UnitedHealth
The shares of health insurer UnitedHealth (UNH) and a number of other companies in the sector are falling after the Dow member lowered its fiscal 2015 profit guidance, citing weakness in individual health insurance policies it markets through exchanges. WHAT'S NEW: UnitedHealth lowered its fiscal 2015 earnings per share guidance to $6 from $6.25-$6.35. Analysts' consensus estimate was $6.31. The company identified policies sold to individuals through exchanges as the culprit. UnitedHealth said it expects to lose 26c per share on these policies in 2015 and 2016. The insurer stated that its other businesses were performing in-line with expectations and showing strength. UnitedHealth said it has pulled back on its marketing efforts for individual exchange products in 2016 and indicated that it would consider offering fewer individual policies through exchanges in 2017. UnitedHealth provided fiscal 2016 EPS guidance of $7.10-$7.30, versus the consensus outlook of $7.28. ANALYST REACTION: Any weakness in UnitedHealth and other health insurers today on the news from UnitedHealth creates a strong buying opportunity, Leerink Swann analyst Ana Gupte wrote in a note to investors today. The government will either reform the exchanges to make them more profitable for the insurers or they will exit the market, Gupte predicted. Moreover, the downside risk for health insurers Aetna (AET), Anthem (ANTM), Humana (HUM), and Cigna (CI) from today's news are low, since their Q3 and 2016 outlooks already incorporated the negative trends cited by UnitedHealth, the analyst stated. Mizuho Securities analyst Sheryl Skolnick was more cautious, predicting that the news would "rattle" the health insurance sector. United Health is more "insulated" than its peers from the weakness of the exchanges because its exposure to the market is relatively limited and its business is more diversified than that of its peers, according to Skolnick, who kept a $150 price target and Buy rating on the stock. Meanwhile, Piper Jaffray analyst Sean Wieland says UnitedHealth reducing its exchange exposure should be accretive to shareholder value. The company's participation in exchanges is not essential to its growth strategy, according to Wieland. The issues cited for the guidance cut likely applies to all Managed Care companies, therefore UnitedHealth should outperform peers given its limited exposure to exchanges, contends Wieland, who reiterated an Overweight rating on the stock with a $149 price target. PRICE ACTION: In morning trading, UnitedHealth fell 4% to $112.49, Aetna declined 4.4% to $102.18, Humana gave back 2.4% to $167, Anthem fell 6.6% to $128.20, and Cigna slid 3.8% to $130.
10:39 EDTUNHUnitedHealth growth not dependent on exchanges, says Piper Jaffray
Subscribe for More Information
10:23 EDTUNH, AET, CI, CNC, HUM, HNT, MOHUnitedHealth selloff on guidance presents buying opportunity, says Leerink
Subscribe for More Information
10:00 EDTUNHUnitedHealth pulls back on marketing efforts for individual exchange programs
UnitedHealthcare announced it has pulled back on its marketing efforts for individual exchange products in 2016. The company is evaluating the viability of the insurance exchange product segment and will determine during the first half of 2016 to what extent it can continue to serve the public exchange markets in 2017.
09:16 EDTUNHUnitedHealth falls on FY15 guidance
Subscribe for More Information
07:46 EDTCNC, WCG, CI, HNT, HUM, UNH, AETOptions expected to be active; UNH AET ANTM CI WCG HUM HNT CNC
Subscribe for More Information
06:40 EDTUNHUnitedHealth volatility flat into lowering FY15 guidance
Subscribe for More Information
06:11 EDTUNHUnitedHealth to host conference call
Subscribe for More Information
05:59 EDTUNHUnitedHealth cuts FY15 to $6.00 from $6.25-$6.35
Subscribe for More Information
05:57 EDTUNHUnitedHealth sees FY16 EPS $7.10-$7.30, consensus $7.28
Subscribe for More Information
November 18, 2015
17:51 EDTMOHMolina Healthcare subsidiary selected for Medicaid contract awards in Washington
Subscribe for More Information
15:40 EDTUNHCongressman says U.S. may need look at pharmacy competition, dealReporter says
Subscribe for More Information
November 17, 2015
09:05 EDTUNHOptumRx acquires AxelaCare
Subscribe for More Information
08:04 EDTWCGStifel to hold a conference
Subscribe for More Information
November 16, 2015
09:59 EDTCIOmega bought Valeant in Q3, sold some SuneEdison
Leon Cooperman's Omega Advisors gave a quarterly update on its stakes in a filing this morning, disclosing its positions as of September 30. NEW STAKES: Pfizer (PFE), Valeant (VRX) Walgreens Boots Alliance (WBA), TerraForm Global (GLBL), Cigna (CI). INCREASED STAKES: Google Class A (GOOGL), Facebook (FB), Delta Air Lines (DAL). DECREASED STAKES: SunEdison (SUNE), Shire (SHPG), Citi (C), KAR Auction (KAR), LyondellBasell (LYB). LIQUIDATED STAKES: McKesson (MCK), 21st Century Fox (FOXA), General Motors (GM), QEP Resources (QEP), eBay (EBAY).
09:06 EDTUNHDiplomat seen as compelling amid specialty pharmacy fallout
Shares of specialty pharmacy operator Diplomat Pharmacy (DPLO) and pharmacy benefit manager Express Scripts (ESRX) have each been knocked down by the negative news surrounding the sector amid the troubles faced by Valeant (VRX) and others, but an analyst at Leerink contends in a note to investors that the pullbacks in both stocks provide buying opportunities. BACKGROUND: Drugmaker Valeant and its prior specialty pharmacy partner, Philidor Rx Services, have been at the center of the firestorm engulfing the sector. Following claims that Philidor urged its employees to modify prescriptions to ensure more orders of Valeant-branded drugs rather than generics, as well as other allegations of wrongdoing, Express Scripts (ESRX) and peer CVS Health (CVS) terminated Philidor from their networks. The day after those termination announcements, Valeant said that it was severing all ties with Philidor and that the pharmacy planned to shut down operations as soon as possible, consistent with applicable laws. Valeant has subsequently said that Philidor has committed to cease operations by January 30, 2016, at the latest. More recently, Express Scripts, the nation's largest pharmacy benefit manager, announced that it stopped doing business with Linden Care, accusing it of being a "captive" pharmacy that dispenses mostly products made by Horizon Pharma (HZNP). In turn, Horizon called the idea that Linden Care is a captive pharmacy "entirely false," stating that "at best Express Scripts is being reckless in its allegations and at worse it is intentionally attempting to mislead investors." Express Scripts' move also impacted shares of Insys Therapeutics (INSY), which reportedly also used Linden Care to fulfill prescription for its drugs. DIPLOMAT LIKELY TO STAY IN-NETWORK: Leerink analyst David Larsen acknowledged that recent events indicate that Express Scripts appears to be evaluating certain retail pharmacies and their relationships with manufacturers, but he believes Diplomat's mix of drugs for diseases like multiple sclerosis, HIV, hepatitis C and cancer differentiate it as a "true" specialty pharmacy. Larsen does not think Diplomat is at risk of being excluded from the pharmacy networks of Express Scripts, CVS or UnitedHealth's (UNH) Optum, he tells investors. Larsen expects limited distribution agreements to stay an important channel strategy for drugmakers and believes these agreements are appropriate for high cost specialty drugs that require special handling and additional services to manage patient adherence. The analyst, who thinks Diplomat remains well positioned to deliver annual growth of over 30% in the next several years, keeps an Outperform rating on its shares. EXPRESS BUYING OPPORTUNITY: Larsen also thinks concerns around manufacturer and pharmacy relationships have put unwarranted pressure on shares of Express Scripts. He does not expect Express Scripts to disclose new lawsuits around rebate dollars owed over other manufacturer disputes and keeps an Outperform rating on the stock, which he views as having an "attractive" valuation. WHAT'S NOTABLE: Larsen also thinks that the specialty channel remains an opportunity for Walgreens Boots Alliance (WBA) and believes its proposed acquisition of Rite Aid (RAD) can strengthen its specialty offering. The analyst keeps an Outperform rating on Walgreens shares as well. PRICE ACTION: Over the last three months, Diplomat Pharmacy shares have declined 28%, Express Scripts has fallen 6% and Walgreens has dropped 14%.
06:02 EDTCIAnthem announces ISS recommends shareholders vote "For" Cigna acquisition
Anthem (ANTM) announced that Institutional Shareholder Services has issued a report recommending that Anthem shareholders vote to approve the issuance of Anthem stock in the proposed acquisition of Cigna (CI) at the company's special meeting of shareholders to be held on Thursday, December 3, 2015. Anthem's board unanimously recommends that Anthem shareholders vote "FOR" the proposal to issue Anthem common stock to acquire Cigna, which is necessary to complete the transaction.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use